The purpose of the recommended approaches is to help stakeholders develop highly effective, evidence-based, drug-drug interaction (DDI) clinical decision support. The recommended approaches are intended to be reflective of the best evidence currently available.

consensus discussion about selection potential drug-drug interactions for decision support

Recommendations for selecting drug–drug Interactions for clinical decision support This paper describes recommendations by a work group to create a process to establish a standard set of DDIs for clinical decision support.

consensus discussion about how to synthesize evidence about potential drug-drug interactions

Consensus recommendations for systematic evaluation of drug–drug interaction evidence for clinical decision support This paper provides recommendations for systematic evaluation of evidence from the scientific literature, drug product labeling, and regulatory documents with respect to DDIs for clinical decision support.

consensus discussion about how to make drug-drug interaction decision support more usable

Recommendations to improve the usability of drug-drug interaction clinical decision support alerts This paper establishes preferred strategies for presenting DDI clinical decision support alerts.

a group photo from a prior meeting of stakeholders for drug-drug interaction decision support

A minimum information model for the representation of potential drug-drug interaction knowledge and evidence This report provides recommendations for a minimum information model for information about potential DDIs.